INGREZZA Normalized: ingrezza |
Drug |
Neurocrine BioSciences, Inc. |
$112,618.21 |
124 |
2025 |
Source payment records
-
2025-01-23 · Neurocrine BioSciences, Inc. · $2,975.00 ·
Open Payments source
-
2025-01-23 · Neurocrine BioSciences, Inc. · $181.80 ·
Open Payments source
-
2025-01-23 · Neurocrine BioSciences, Inc. · $126.80 ·
Open Payments source
-
2025-01-23 · Neurocrine BioSciences, Inc. · $111.05 ·
Open Payments source
-
2025-02-05 · Neurocrine BioSciences, Inc. · $4,038.00 ·
Open Payments source
-
2025-02-05 · Neurocrine BioSciences, Inc. · $358.97 ·
Open Payments source
-
2025-02-05 · Neurocrine BioSciences, Inc. · $289.12 ·
Open Payments source
-
2025-02-05 · Neurocrine BioSciences, Inc. · $163.48 ·
Open Payments source
-
2025-02-05 · Neurocrine BioSciences, Inc. · $107.83 ·
Open Payments source
-
2025-02-05 · Neurocrine BioSciences, Inc. · $55.02 ·
Open Payments source
-
2025-02-05 · Neurocrine BioSciences, Inc. · $37.86 ·
Open Payments source
-
2025-02-05 · Neurocrine BioSciences, Inc. · $7.56 ·
Open Payments source
-
2025-02-05 · Neurocrine BioSciences, Inc. · $4.90 ·
Open Payments source
-
2025-02-11 · Neurocrine BioSciences, Inc. · $2,975.00 ·
Open Payments source
-
2025-02-11 · Neurocrine BioSciences, Inc. · $873.90 ·
Open Payments source
-
2025-02-11 · Neurocrine BioSciences, Inc. · $163.06 ·
Open Payments source
-
2025-02-13 · Neurocrine BioSciences, Inc. · $6.90 ·
Open Payments source
-
2025-02-21 · Neurocrine BioSciences, Inc. · $1,900.00 ·
Open Payments source
-
2025-02-26 · Neurocrine BioSciences, Inc. · $4,513.00 ·
Open Payments source
-
2025-02-26 · Neurocrine BioSciences, Inc. · $590.95 ·
Open Payments source
-
2025-02-26 · Neurocrine BioSciences, Inc. · $363.99 ·
Open Payments source
-
2025-02-26 · Neurocrine BioSciences, Inc. · $337.79 ·
Open Payments source
-
2025-02-26 · Neurocrine BioSciences, Inc. · $229.84 ·
Open Payments source
-
2025-02-26 · Neurocrine BioSciences, Inc. · $140.00 ·
Open Payments source
-
2025-02-26 · Neurocrine BioSciences, Inc. · $20.20 ·
Open Payments source
-
2025-03-07 · Neurocrine BioSciences, Inc. · $175.00 ·
Open Payments source
-
2025-03-07 · Neurocrine BioSciences, Inc. · $91.00 ·
Open Payments source
-
2025-03-07 · Neurocrine BioSciences, Inc. · $31.29 ·
Open Payments source
-
2025-03-08 · Neurocrine BioSciences, Inc. · $235.54 ·
Open Payments source
-
2025-03-08 · Neurocrine BioSciences, Inc. · $61.72 ·
Open Payments source
-
2025-03-08 · Neurocrine BioSciences, Inc. · $54.80 ·
Open Payments source
-
2025-03-08 · Neurocrine BioSciences, Inc. · $37.65 ·
Open Payments source
-
2025-03-08 · Neurocrine BioSciences, Inc. · $32.29 ·
Open Payments source
-
2025-03-08 · Neurocrine BioSciences, Inc. · $9.85 ·
Open Payments source
-
2025-03-08 · Neurocrine BioSciences, Inc. · $6.60 ·
Open Payments source
-
2025-03-12 · Neurocrine BioSciences, Inc. · $3,800.00 ·
Open Payments source
-
2025-03-12 · Neurocrine BioSciences, Inc. · $434.77 ·
Open Payments source
-
2025-03-12 · Neurocrine BioSciences, Inc. · $420.60 ·
Open Payments source
-
2025-03-12 · Neurocrine BioSciences, Inc. · $151.27 ·
Open Payments source
-
2025-03-13 · Neurocrine BioSciences, Inc. · $1,900.00 ·
Open Payments source
-
2025-03-13 · Neurocrine BioSciences, Inc. · $8.23 ·
Open Payments source
-
2025-04-03 · Neurocrine BioSciences, Inc. · $7,125.00 ·
Open Payments source
-
2025-04-03 · Neurocrine BioSciences, Inc. · $7.08 ·
Open Payments source
-
2025-04-15 · Neurocrine BioSciences, Inc. · $25.38 ·
Open Payments source
-
2025-05-02 · Neurocrine BioSciences, Inc. · $3,088.00 ·
Open Payments source
-
2025-05-14 · Neurocrine BioSciences, Inc. · $4,513.00 ·
Open Payments source
-
2025-05-14 · Neurocrine BioSciences, Inc. · $236.96 ·
Open Payments source
-
2025-05-14 · Neurocrine BioSciences, Inc. · $190.97 ·
Open Payments source
-
2025-05-14 · Neurocrine BioSciences, Inc. · $120.38 ·
Open Payments source
-
2025-05-14 · Neurocrine BioSciences, Inc. · $102.36 ·
Open Payments source
-
2025-05-14 · Neurocrine BioSciences, Inc. · $94.81 ·
Open Payments source
-
2025-05-14 · Neurocrine BioSciences, Inc. · $83.96 ·
Open Payments source
-
2025-05-14 · Neurocrine BioSciences, Inc. · $80.51 ·
Open Payments source
-
2025-05-14 · Neurocrine BioSciences, Inc. · $4.99 ·
Open Payments source
-
2025-05-15 · Neurocrine BioSciences, Inc. · $3,088.00 ·
Open Payments source
-
2025-05-15 · Neurocrine BioSciences, Inc. · $231.56 ·
Open Payments source
-
2025-05-15 · Neurocrine BioSciences, Inc. · $224.00 ·
Open Payments source
-
2025-05-15 · Neurocrine BioSciences, Inc. · $128.63 ·
Open Payments source
-
2025-05-20 · Neurocrine BioSciences, Inc. · $3,088.00 ·
Open Payments source
-
2025-05-20 · Neurocrine BioSciences, Inc. · $170.40 ·
Open Payments source
-
2025-05-20 · Neurocrine BioSciences, Inc. · $125.00 ·
Open Payments source
-
2025-05-20 · Neurocrine BioSciences, Inc. · $24.00 ·
Open Payments source
-
2025-05-20 · Neurocrine BioSciences, Inc. · $11.20 ·
Open Payments source
-
2025-06-13 · Neurocrine BioSciences, Inc. · $3,800.00 ·
Open Payments source
-
2025-06-13 · Neurocrine BioSciences, Inc. · $931.66 ·
Open Payments source
-
2025-06-13 · Neurocrine BioSciences, Inc. · $172.46 ·
Open Payments source
-
2025-06-13 · Neurocrine BioSciences, Inc. · $479.94 ·
Open Payments source
-
2025-06-13 · Neurocrine BioSciences, Inc. · $479.94 ·
Open Payments source
-
2025-07-13 · Neurocrine BioSciences, Inc. · $22.16 ·
Open Payments source
-
2025-08-26 · Neurocrine BioSciences, Inc. · $3,800.00 ·
Open Payments source
-
2025-08-26 · Neurocrine BioSciences, Inc. · $369.56 ·
Open Payments source
-
2025-08-26 · Neurocrine BioSciences, Inc. · $320.74 ·
Open Payments source
-
2025-08-26 · Neurocrine BioSciences, Inc. · $167.00 ·
Open Payments source
-
2025-08-27 · Neurocrine BioSciences, Inc. · $19.00 ·
Open Payments source
-
2025-09-04 · Neurocrine BioSciences, Inc. · $3,800.00 ·
Open Payments source
-
2025-09-04 · Neurocrine BioSciences, Inc. · $437.28 ·
Open Payments source
-
2025-09-04 · Neurocrine BioSciences, Inc. · $288.84 ·
Open Payments source
-
2025-09-04 · Neurocrine BioSciences, Inc. · $11.05 ·
Open Payments source
-
2025-09-09 · Neurocrine BioSciences, Inc. · $3,088.00 ·
Open Payments source
-
2025-09-09 · Neurocrine BioSciences, Inc. · $190.44 ·
Open Payments source
-
2025-09-09 · Neurocrine BioSciences, Inc. · $164.73 ·
Open Payments source
-
2025-09-09 · Neurocrine BioSciences, Inc. · $139.59 ·
Open Payments source
-
2025-09-17 · Neurocrine BioSciences, Inc. · $1,900.00 ·
Open Payments source
-
2025-09-18 · Neurocrine BioSciences, Inc. · $5,225.00 ·
Open Payments source
-
2025-09-18 · Neurocrine BioSciences, Inc. · $3,088.00 ·
Open Payments source
-
2025-09-18 · Neurocrine BioSciences, Inc. · $723.75 ·
Open Payments source
-
2025-09-18 · Neurocrine BioSciences, Inc. · $641.40 ·
Open Payments source
-
2025-09-18 · Neurocrine BioSciences, Inc. · $336.91 ·
Open Payments source
-
2025-09-18 · Neurocrine BioSciences, Inc. · $256.80 ·
Open Payments source
-
2025-09-18 · Neurocrine BioSciences, Inc. · $203.16 ·
Open Payments source
-
2025-09-18 · Neurocrine BioSciences, Inc. · $55.81 ·
Open Payments source
-
2025-09-18 · Neurocrine BioSciences, Inc. · $47.17 ·
Open Payments source
-
2025-09-18 · Neurocrine BioSciences, Inc. · $16.85 ·
Open Payments source
-
2025-09-18 · Neurocrine BioSciences, Inc. · $15.55 ·
Open Payments source
-
2025-09-19 · Neurocrine BioSciences, Inc. · $3,088.00 ·
Open Payments source
-
2025-09-19 · Neurocrine BioSciences, Inc. · $246.11 ·
Open Payments source
-
2025-09-19 · Neurocrine BioSciences, Inc. · $139.89 ·
Open Payments source
-
2025-09-19 · Neurocrine BioSciences, Inc. · $80.95 ·
Open Payments source
-
2025-09-23 · Neurocrine BioSciences, Inc. · $4,513.00 ·
Open Payments source
-
2025-09-23 · Neurocrine BioSciences, Inc. · $383.06 ·
Open Payments source
-
2025-09-23 · Neurocrine BioSciences, Inc. · $336.48 ·
Open Payments source
-
2025-09-23 · Neurocrine BioSciences, Inc. · $326.48 ·
Open Payments source
-
2025-09-23 · Neurocrine BioSciences, Inc. · $225.42 ·
Open Payments source
-
2025-09-23 · Neurocrine BioSciences, Inc. · $220.59 ·
Open Payments source
-
2025-09-23 · Neurocrine BioSciences, Inc. · $120.31 ·
Open Payments source
-
2025-09-23 · Neurocrine BioSciences, Inc. · $89.81 ·
Open Payments source
-
2025-09-23 · Neurocrine BioSciences, Inc. · $34.27 ·
Open Payments source
-
2025-09-23 · Neurocrine BioSciences, Inc. · $22.06 ·
Open Payments source
-
2025-09-26 · Neurocrine BioSciences, Inc. · $3,088.00 ·
Open Payments source
-
2025-09-26 · Neurocrine BioSciences, Inc. · $159.04 ·
Open Payments source
-
2025-10-30 · Neurocrine BioSciences, Inc. · $3,800.00 ·
Open Payments source
-
2025-10-30 · Neurocrine BioSciences, Inc. · $371.86 ·
Open Payments source
-
2025-10-30 · Neurocrine BioSciences, Inc. · $355.46 ·
Open Payments source
-
2025-10-30 · Neurocrine BioSciences, Inc. · $158.48 ·
Open Payments source
-
2025-10-31 · Neurocrine BioSciences, Inc. · $19.00 ·
Open Payments source
-
2025-11-13 · Neurocrine BioSciences, Inc. · $1.50 ·
Open Payments source
-
2025-11-18 · Neurocrine BioSciences, Inc. · $3,800.00 ·
Open Payments source
-
2025-11-18 · Neurocrine BioSciences, Inc. · $346.06 ·
Open Payments source
-
2025-11-26 · Neurocrine BioSciences, Inc. · $3,800.00 ·
Open Payments source
-
2025-12-02 · Neurocrine BioSciences, Inc. · $3,800.00 ·
Open Payments source
-
2025-12-02 · Neurocrine BioSciences, Inc. · $469.01 ·
Open Payments source
-
2025-12-02 · Neurocrine BioSciences, Inc. · $199.15 ·
Open Payments source
-
2025-12-02 · Neurocrine BioSciences, Inc. · $146.91 ·
Open Payments source
-
2025-12-22 · Neurocrine BioSciences, Inc. · $297.70 ·
Open Payments source
|
FANAPT Normalized: fanapt |
Drug |
Vanda Pharmaceuticals Inc. |
$87,134.55 |
88 |
2025 |
Source payment records
-
2025-01-06 · Vanda Pharmaceuticals Inc. · $29.07 ·
Open Payments source
-
2025-01-06 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-01-06 · Vanda Pharmaceuticals Inc. · $8.40 ·
Open Payments source
-
2025-02-06 · Vanda Pharmaceuticals Inc. · $33.73 ·
Open Payments source
-
2025-02-06 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-02-06 · Vanda Pharmaceuticals Inc. · $108.23 ·
Open Payments source
-
2025-03-25 · Vanda Pharmaceuticals Inc. · $125.00 ·
Open Payments source
-
2025-03-25 · Vanda Pharmaceuticals Inc. · $3,120.00 ·
Open Payments source
-
2025-03-25 · Vanda Pharmaceuticals Inc. · $1,039.60 ·
Open Payments source
-
2025-03-25 · Vanda Pharmaceuticals Inc. · $15.60 ·
Open Payments source
-
2025-04-24 · Vanda Pharmaceuticals Inc. · $16.91 ·
Open Payments source
-
2025-04-24 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-04-24 · Vanda Pharmaceuticals Inc. · $145.19 ·
Open Payments source
-
2025-06-09 · Vanda Pharmaceuticals Inc. · $26.69 ·
Open Payments source
-
2025-06-09 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-06-09 · Vanda Pharmaceuticals Inc. · $11.90 ·
Open Payments source
-
2025-06-11 · Vanda Pharmaceuticals Inc. · $33.63 ·
Open Payments source
-
2025-06-11 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-06-11 · Vanda Pharmaceuticals Inc. · $75.76 ·
Open Payments source
-
2025-06-30 · Vanda Pharmaceuticals Inc. · $35.56 ·
Open Payments source
-
2025-06-30 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-06-30 · Vanda Pharmaceuticals Inc. · $769.48 ·
Open Payments source
-
2025-08-12 · Vanda Pharmaceuticals Inc. · $38.45 ·
Open Payments source
-
2025-08-12 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-08-12 · Vanda Pharmaceuticals Inc. · $842.00 ·
Open Payments source
-
2025-08-14 · Vanda Pharmaceuticals Inc. · $124.99 ·
Open Payments source
-
2025-08-14 · Vanda Pharmaceuticals Inc. · $3,120.00 ·
Open Payments source
-
2025-08-14 · Vanda Pharmaceuticals Inc. · $832.10 ·
Open Payments source
-
2025-08-15 · Vanda Pharmaceuticals Inc. · $744.37 ·
Open Payments source
-
2025-08-15 · Vanda Pharmaceuticals Inc. · $7,020.00 ·
Open Payments source
-
2025-08-15 · Vanda Pharmaceuticals Inc. · $178.12 ·
Open Payments source
-
2025-08-15 · Vanda Pharmaceuticals Inc. · $225.00 ·
Open Payments source
-
2025-08-15 · Vanda Pharmaceuticals Inc. · $48.14 ·
Open Payments source
-
2025-08-15 · Vanda Pharmaceuticals Inc. · $219.22 ·
Open Payments source
-
2025-08-15 · Vanda Pharmaceuticals Inc. · $207.46 ·
Open Payments source
-
2025-08-16 · Vanda Pharmaceuticals Inc. · $3.99 ·
Open Payments source
-
2025-08-16 · Vanda Pharmaceuticals Inc. · $69.90 ·
Open Payments source
-
2025-08-16 · Vanda Pharmaceuticals Inc. · $29.52 ·
Open Payments source
-
2025-08-16 · Vanda Pharmaceuticals Inc. · $32.61 ·
Open Payments source
-
2025-08-16 · Vanda Pharmaceuticals Inc. · $49.55 ·
Open Payments source
-
2025-08-16 · Vanda Pharmaceuticals Inc. · $2.66 ·
Open Payments source
-
2025-08-16 · Vanda Pharmaceuticals Inc. · $79.73 ·
Open Payments source
-
2025-08-19 · Vanda Pharmaceuticals Inc. · $27.61 ·
Open Payments source
-
2025-08-19 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-08-19 · Vanda Pharmaceuticals Inc. · $579.27 ·
Open Payments source
-
2025-08-20 · Vanda Pharmaceuticals Inc. · $25.86 ·
Open Payments source
-
2025-08-20 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-08-20 · Vanda Pharmaceuticals Inc. · $249.59 ·
Open Payments source
-
2025-09-03 · Vanda Pharmaceuticals Inc. · $28.72 ·
Open Payments source
-
2025-09-03 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-09-03 · Vanda Pharmaceuticals Inc. · $926.70 ·
Open Payments source
-
2025-09-03 · Vanda Pharmaceuticals Inc. · $11.70 ·
Open Payments source
-
2025-09-05 · Vanda Pharmaceuticals Inc. · $26.62 ·
Open Payments source
-
2025-09-05 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-09-05 · Vanda Pharmaceuticals Inc. · $897.50 ·
Open Payments source
-
2025-09-10 · Vanda Pharmaceuticals Inc. · $39.78 ·
Open Payments source
-
2025-09-10 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-09-10 · Vanda Pharmaceuticals Inc. · $869.76 ·
Open Payments source
-
2025-09-16 · Vanda Pharmaceuticals Inc. · $29.27 ·
Open Payments source
-
2025-09-16 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-09-16 · Vanda Pharmaceuticals Inc. · $5.88 ·
Open Payments source
-
2025-09-16 · Vanda Pharmaceuticals Inc. · $124.85 ·
Open Payments source
-
2025-09-16 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-10-02 · Vanda Pharmaceuticals Inc. · $21.30 ·
Open Payments source
-
2025-10-02 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-10-02 · Vanda Pharmaceuticals Inc. · $15.40 ·
Open Payments source
-
2025-10-06 · Vanda Pharmaceuticals Inc. · $35.00 ·
Open Payments source
-
2025-10-06 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-10-06 · Vanda Pharmaceuticals Inc. · $12.60 ·
Open Payments source
-
2025-10-14 · Vanda Pharmaceuticals Inc. · $23.62 ·
Open Payments source
-
2025-10-14 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-10-14 · Vanda Pharmaceuticals Inc. · $844.24 ·
Open Payments source
-
2025-10-20 · Vanda Pharmaceuticals Inc. · $3,120.00 ·
Open Payments source
-
2025-10-20 · Vanda Pharmaceuticals Inc. · $437.30 ·
Open Payments source
-
2025-10-20 · Vanda Pharmaceuticals Inc. · $58.72 ·
Open Payments source
-
2025-11-10 · Vanda Pharmaceuticals Inc. · $22.49 ·
Open Payments source
-
2025-11-18 · Vanda Pharmaceuticals Inc. · $30.91 ·
Open Payments source
-
2025-11-18 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-11-18 · Vanda Pharmaceuticals Inc. · $566.59 ·
Open Payments source
-
2025-11-20 · Vanda Pharmaceuticals Inc. · $123.38 ·
Open Payments source
-
2025-11-20 · Vanda Pharmaceuticals Inc. · $3,900.00 ·
Open Payments source
-
2025-11-20 · Vanda Pharmaceuticals Inc. · $1,119.50 ·
Open Payments source
-
2025-12-01 · Vanda Pharmaceuticals Inc. · $29.42 ·
Open Payments source
-
2025-12-01 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-12-01 · Vanda Pharmaceuticals Inc. · $881.28 ·
Open Payments source
-
2025-12-17 · Vanda Pharmaceuticals Inc. · $27.51 ·
Open Payments source
-
2025-12-17 · Vanda Pharmaceuticals Inc. · $2,600.00 ·
Open Payments source
-
2025-12-17 · Vanda Pharmaceuticals Inc. · $559.62 ·
Open Payments source
|
CAPLYTA Normalized: caplyta |
Drug |
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
$67,048.99 |
65 |
2025 |
Source payment records
-
2025-02-06 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $4,320.00 ·
Open Payments source
-
2025-02-06 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $914.65 ·
Open Payments source
-
2025-02-18 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $25.59 ·
Open Payments source
-
2025-02-18 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $3,780.00 ·
Open Payments source
-
2025-02-18 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $789.70 ·
Open Payments source
-
2025-02-20 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $29.18 ·
Open Payments source
-
2025-02-20 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2,160.00 ·
Open Payments source
-
2025-02-20 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $12.60 ·
Open Payments source
-
2025-03-13 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $128.95 ·
Open Payments source
-
2025-04-23 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2,700.00 ·
Open Payments source
-
2025-04-23 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $689.74 ·
Open Payments source
-
2025-05-29 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $1,210.18 ·
Open Payments source
-
2025-05-29 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $125.00 ·
Open Payments source
-
2025-06-18 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $123.86 ·
Open Payments source
-
2025-06-18 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $4,440.00 ·
Open Payments source
-
2025-06-18 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $948.39 ·
Open Payments source
-
2025-07-02 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $4,440.00 ·
Open Payments source
-
2025-07-11 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $38.78 ·
Open Payments source
-
2025-07-31 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $4,440.00 ·
Open Payments source
-
2025-08-18 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $124.31 ·
Open Payments source
-
2025-08-28 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $4,440.00 ·
Open Payments source
-
2025-08-28 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $48.30 ·
Open Payments source
-
2025-08-28 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $374.68 ·
Open Payments source
-
2025-10-02 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $6.58 ·
Open Payments source
-
2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $138.53 ·
Open Payments source
-
2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $24.29 ·
Open Payments source
-
2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $24.29 ·
Open Payments source
-
2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $275.45 ·
Open Payments source
-
2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $44.30 ·
Open Payments source
-
2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $46.64 ·
Open Payments source
-
2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $52.94 ·
Open Payments source
-
2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $525.97 ·
Open Payments source
-
2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $59.43 ·
Open Payments source
-
2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $91.67 ·
Open Payments source
-
2025-10-29 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $3.45 ·
Open Payments source
-
2025-10-31 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $182.31 ·
Open Payments source
-
2025-11-12 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $25.78 ·
Open Payments source
-
2025-11-12 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $186.38 ·
Open Payments source
-
2025-11-12 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $231.89 ·
Open Payments source
-
2025-11-12 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $68.37 ·
Open Payments source
-
2025-11-13 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $27.32 ·
Open Payments source
-
2025-11-17 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $4,440.00 ·
Open Payments source
-
2025-11-25 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2,775.00 ·
Open Payments source
-
2025-11-25 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $272.69 ·
Open Payments source
-
2025-11-25 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $209.55 ·
Open Payments source
-
2025-12-08 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $26.14 ·
Open Payments source
-
2025-12-09 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $119.00 ·
Open Payments source
-
2025-12-10 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $129.99 ·
Open Payments source
-
2025-12-10 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $128.24 ·
Open Payments source
-
2025-12-10 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $9.80 ·
Open Payments source
-
2025-12-10 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $1,665.00 ·
Open Payments source
-
2025-12-12 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2,220.00 ·
Open Payments source
-
2025-12-12 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2,775.00 ·
Open Payments source
-
2025-12-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $123.22 ·
Open Payments source
-
2025-12-16 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $279.33 ·
Open Payments source
-
2025-12-16 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $350.69 ·
Open Payments source
-
2025-12-17 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $4,440.00 ·
Open Payments source
-
2025-12-17 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2,220.00 ·
Open Payments source
-
2025-12-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $15.40 ·
Open Payments source
-
2025-12-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $324.79 ·
Open Payments source
-
2025-12-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $182.44 ·
Open Payments source
-
2025-12-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $195.98 ·
Open Payments source
-
2025-12-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $277.23 ·
Open Payments source
-
2025-12-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2,775.00 ·
Open Payments source
-
2025-12-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2,775.00 ·
Open Payments source
|
INVEGA SUSTENNA Normalized: invega sustenna |
Drug |
Janssen Pharmaceuticals, Inc |
$57,855.47 |
56 |
2025 |
Source payment records
-
2025-03-14 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-03-14 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-03-18 · Janssen Pharmaceuticals, Inc · $145.00 ·
Open Payments source
-
2025-03-19 · Janssen Pharmaceuticals, Inc · $740.61 ·
Open Payments source
-
2025-03-26 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-03-26 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-03-26 · Janssen Pharmaceuticals, Inc · $138.56 ·
Open Payments source
-
2025-03-26 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-03-26 · Janssen Pharmaceuticals, Inc · $3,510.00 ·
Open Payments source
-
2025-03-28 · Janssen Pharmaceuticals, Inc · $984.59 ·
Open Payments source
-
2025-03-31 · Janssen Pharmaceuticals, Inc · $4,095.00 ·
Open Payments source
-
2025-04-02 · Janssen Pharmaceuticals, Inc · $149.53 ·
Open Payments source
-
2025-04-10 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-04-17 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-04-17 · Janssen Pharmaceuticals, Inc · $148.84 ·
Open Payments source
-
2025-04-17 · Janssen Pharmaceuticals, Inc · $789.42 ·
Open Payments source
-
2025-04-21 · Janssen Pharmaceuticals, Inc · $3,510.00 ·
Open Payments source
-
2025-04-21 · Janssen Pharmaceuticals, Inc · $129.72 ·
Open Payments source
-
2025-04-22 · Janssen Pharmaceuticals, Inc · $698.65 ·
Open Payments source
-
2025-04-22 · Janssen Pharmaceuticals, Inc · $135.31 ·
Open Payments source
-
2025-04-23 · Janssen Pharmaceuticals, Inc · $789.42 ·
Open Payments source
-
2025-04-23 · Janssen Pharmaceuticals, Inc · $3,510.00 ·
Open Payments source
-
2025-04-23 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-04-25 · Janssen Pharmaceuticals, Inc · $505.70 ·
Open Payments source
-
2025-04-25 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-04-25 · Janssen Pharmaceuticals, Inc · $4,095.00 ·
Open Payments source
-
2025-04-28 · Janssen Pharmaceuticals, Inc · $74.60 ·
Open Payments source
-
2025-04-30 · Janssen Pharmaceuticals, Inc · $3,510.00 ·
Open Payments source
-
2025-05-07 · Janssen Pharmaceuticals, Inc · $101.75 ·
Open Payments source
-
2025-05-13 · Janssen Pharmaceuticals, Inc · $1,292.35 ·
Open Payments source
-
2025-05-13 · Janssen Pharmaceuticals, Inc · $4,095.00 ·
Open Payments source
-
2025-05-21 · Janssen Pharmaceuticals, Inc · $432.46 ·
Open Payments source
-
2025-05-23 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-06-04 · Janssen Pharmaceuticals, Inc · $634.74 ·
Open Payments source
-
2025-06-04 · Janssen Pharmaceuticals, Inc · $150.00 ·
Open Payments source
-
2025-06-05 · Janssen Pharmaceuticals, Inc · $3,510.00 ·
Open Payments source
-
2025-06-13 · Janssen Pharmaceuticals, Inc · $204.27 ·
Open Payments source
-
2025-06-13 · Janssen Pharmaceuticals, Inc · $675.12 ·
Open Payments source
-
2025-06-17 · Janssen Pharmaceuticals, Inc · $4,095.00 ·
Open Payments source
-
2025-06-18 · Janssen Pharmaceuticals, Inc · $149.47 ·
Open Payments source
-
2025-06-24 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-06-30 · Janssen Pharmaceuticals, Inc · $146.56 ·
Open Payments source
-
2025-07-10 · Janssen Pharmaceuticals, Inc · $585.00 ·
Open Payments source
-
2025-07-17 · Janssen Pharmaceuticals, Inc · $134.56 ·
Open Payments source
-
2025-07-18 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-07-20 · Janssen Pharmaceuticals, Inc · $702.83 ·
Open Payments source
-
2025-07-25 · Janssen Pharmaceuticals, Inc · $3,510.00 ·
Open Payments source
-
2025-07-31 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-08-21 · Janssen Pharmaceuticals, Inc · $124.97 ·
Open Payments source
-
2025-08-22 · Janssen Pharmaceuticals, Inc · $716.30 ·
Open Payments source
-
2025-08-27 · Janssen Pharmaceuticals, Inc · $3,510.00 ·
Open Payments source
-
2025-09-05 · Janssen Pharmaceuticals, Inc · $71.59 ·
Open Payments source
-
2025-09-05 · Janssen Pharmaceuticals, Inc · $140.75 ·
Open Payments source
-
2025-09-08 · Janssen Pharmaceuticals, Inc · $716.30 ·
Open Payments source
-
2025-09-08 · Janssen Pharmaceuticals, Inc · $3,510.00 ·
Open Payments source
-
2025-12-17 · Janssen Pharmaceuticals, Inc · $915.00 ·
Open Payments source
|
INVEGA TRINZA Normalized: invega trinza |
Drug |
Janssen Pharmaceuticals, Inc |
$56,500.41 |
45 |
2025 |
Source payment records
-
2025-03-14 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-03-14 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-03-19 · Janssen Pharmaceuticals, Inc · $740.61 ·
Open Payments source
-
2025-03-26 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-03-26 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-03-26 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-03-26 · Janssen Pharmaceuticals, Inc · $3,510.00 ·
Open Payments source
-
2025-03-28 · Janssen Pharmaceuticals, Inc · $984.59 ·
Open Payments source
-
2025-03-31 · Janssen Pharmaceuticals, Inc · $4,095.00 ·
Open Payments source
-
2025-04-10 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-04-17 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-04-17 · Janssen Pharmaceuticals, Inc · $148.84 ·
Open Payments source
-
2025-04-17 · Janssen Pharmaceuticals, Inc · $789.42 ·
Open Payments source
-
2025-04-21 · Janssen Pharmaceuticals, Inc · $3,510.00 ·
Open Payments source
-
2025-04-22 · Janssen Pharmaceuticals, Inc · $698.65 ·
Open Payments source
-
2025-04-23 · Janssen Pharmaceuticals, Inc · $789.42 ·
Open Payments source
-
2025-04-23 · Janssen Pharmaceuticals, Inc · $3,510.00 ·
Open Payments source
-
2025-04-23 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-04-25 · Janssen Pharmaceuticals, Inc · $505.70 ·
Open Payments source
-
2025-04-25 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-04-25 · Janssen Pharmaceuticals, Inc · $4,095.00 ·
Open Payments source
-
2025-04-30 · Janssen Pharmaceuticals, Inc · $3,510.00 ·
Open Payments source
-
2025-05-13 · Janssen Pharmaceuticals, Inc · $1,292.35 ·
Open Payments source
-
2025-05-13 · Janssen Pharmaceuticals, Inc · $4,095.00 ·
Open Payments source
-
2025-05-21 · Janssen Pharmaceuticals, Inc · $432.46 ·
Open Payments source
-
2025-05-23 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-06-04 · Janssen Pharmaceuticals, Inc · $634.74 ·
Open Payments source
-
2025-06-04 · Janssen Pharmaceuticals, Inc · $150.00 ·
Open Payments source
-
2025-06-05 · Janssen Pharmaceuticals, Inc · $3,510.00 ·
Open Payments source
-
2025-06-13 · Janssen Pharmaceuticals, Inc · $204.27 ·
Open Payments source
-
2025-06-13 · Janssen Pharmaceuticals, Inc · $675.12 ·
Open Payments source
-
2025-06-17 · Janssen Pharmaceuticals, Inc · $4,095.00 ·
Open Payments source
-
2025-06-24 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-06-30 · Janssen Pharmaceuticals, Inc · $146.56 ·
Open Payments source
-
2025-07-10 · Janssen Pharmaceuticals, Inc · $585.00 ·
Open Payments source
-
2025-07-18 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-07-20 · Janssen Pharmaceuticals, Inc · $702.83 ·
Open Payments source
-
2025-07-25 · Janssen Pharmaceuticals, Inc · $3,510.00 ·
Open Payments source
-
2025-07-31 · Janssen Pharmaceuticals, Inc · $5.50 ·
Open Payments source
-
2025-08-22 · Janssen Pharmaceuticals, Inc · $716.30 ·
Open Payments source
-
2025-08-27 · Janssen Pharmaceuticals, Inc · $3,510.00 ·
Open Payments source
-
2025-09-05 · Janssen Pharmaceuticals, Inc · $140.75 ·
Open Payments source
-
2025-09-08 · Janssen Pharmaceuticals, Inc · $716.30 ·
Open Payments source
-
2025-09-08 · Janssen Pharmaceuticals, Inc · $3,510.00 ·
Open Payments source
-
2025-12-17 · Janssen Pharmaceuticals, Inc · $915.00 ·
Open Payments source
|
COBENFY Normalized: cobenfy |
Drug |
E.R. Squibb & Sons, L.L.C. |
$53,470.40 |
52 |
2025 |
Source payment records
-
2025-01-03 · E.R. Squibb & Sons, L.L.C. · $172.74 ·
Open Payments source
-
2025-01-03 · E.R. Squibb & Sons, L.L.C. · $229.98 ·
Open Payments source
-
2025-01-07 · E.R. Squibb & Sons, L.L.C. · $1,107.50 ·
Open Payments source
-
2025-01-09 · E.R. Squibb & Sons, L.L.C. · $4,984.00 ·
Open Payments source
-
2025-01-09 · E.R. Squibb & Sons, L.L.C. · $4.02 ·
Open Payments source
-
2025-01-09 · E.R. Squibb & Sons, L.L.C. · $95.69 ·
Open Payments source
-
2025-01-21 · E.R. Squibb & Sons, L.L.C. · $39.60 ·
Open Payments source
-
2025-01-28 · E.R. Squibb & Sons, L.L.C. · $120.25 ·
Open Payments source
-
2025-02-14 · E.R. Squibb & Sons, L.L.C. · $1,938.00 ·
Open Payments source
-
2025-02-14 · E.R. Squibb & Sons, L.L.C. · $1,938.00 ·
Open Payments source
-
2025-02-14 · E.R. Squibb & Sons, L.L.C. · $2,769.00 ·
Open Payments source
-
2025-02-14 · E.R. Squibb & Sons, L.L.C. · $107.80 ·
Open Payments source
-
2025-02-20 · E.R. Squibb & Sons, L.L.C. · $1,938.00 ·
Open Payments source
-
2025-03-10 · E.R. Squibb & Sons, L.L.C. · $38.60 ·
Open Payments source
-
2025-03-11 · E.R. Squibb & Sons, L.L.C. · $4.63 ·
Open Payments source
-
2025-03-25 · E.R. Squibb & Sons, L.L.C. · $2,215.00 ·
Open Payments source
-
2025-03-27 · E.R. Squibb & Sons, L.L.C. · $1,938.00 ·
Open Payments source
-
2025-03-28 · E.R. Squibb & Sons, L.L.C. · $331.71 ·
Open Payments source
-
2025-04-07 · E.R. Squibb & Sons, L.L.C. · $484.50 ·
Open Payments source
-
2025-04-24 · E.R. Squibb & Sons, L.L.C. · $23.00 ·
Open Payments source
-
2025-04-30 · E.R. Squibb & Sons, L.L.C. · $120.21 ·
Open Payments source
-
2025-05-15 · E.R. Squibb & Sons, L.L.C. · $2,769.00 ·
Open Payments source
-
2025-05-21 · E.R. Squibb & Sons, L.L.C. · $120.47 ·
Open Payments source
-
2025-06-06 · E.R. Squibb & Sons, L.L.C. · $2,769.00 ·
Open Payments source
-
2025-07-09 · E.R. Squibb & Sons, L.L.C. · $99.75 ·
Open Payments source
-
2025-07-09 · E.R. Squibb & Sons, L.L.C. · $1,050.27 ·
Open Payments source
-
2025-07-16 · E.R. Squibb & Sons, L.L.C. · $133.26 ·
Open Payments source
-
2025-07-31 · E.R. Squibb & Sons, L.L.C. · $2,769.00 ·
Open Payments source
-
2025-08-05 · E.R. Squibb & Sons, L.L.C. · $3,876.00 ·
Open Payments source
-
2025-09-25 · E.R. Squibb & Sons, L.L.C. · $1,938.00 ·
Open Payments source
-
2025-10-09 · E.R. Squibb & Sons, L.L.C. · $779.35 ·
Open Payments source
-
2025-10-09 · E.R. Squibb & Sons, L.L.C. · $326.09 ·
Open Payments source
-
2025-10-09 · E.R. Squibb & Sons, L.L.C. · $29.99 ·
Open Payments source
-
2025-10-09 · E.R. Squibb & Sons, L.L.C. · $29.99 ·
Open Payments source
-
2025-10-09 · E.R. Squibb & Sons, L.L.C. · $49.99 ·
Open Payments source
-
2025-10-09 · E.R. Squibb & Sons, L.L.C. · $64.99 ·
Open Payments source
-
2025-10-09 · E.R. Squibb & Sons, L.L.C. · $134.99 ·
Open Payments source
-
2025-10-09 · E.R. Squibb & Sons, L.L.C. · $51.73 ·
Open Payments source
-
2025-10-21 · E.R. Squibb & Sons, L.L.C. · $299.45 ·
Open Payments source
-
2025-10-21 · E.R. Squibb & Sons, L.L.C. · $349.89 ·
Open Payments source
-
2025-10-21 · E.R. Squibb & Sons, L.L.C. · $434.07 ·
Open Payments source
-
2025-10-29 · E.R. Squibb & Sons, L.L.C. · $950.24 ·
Open Payments source
-
2025-11-03 · E.R. Squibb & Sons, L.L.C. · $4,984.00 ·
Open Payments source
-
2025-11-06 · E.R. Squibb & Sons, L.L.C. · $825.21 ·
Open Payments source
-
2025-11-07 · E.R. Squibb & Sons, L.L.C. · $38.97 ·
Open Payments source
-
2025-11-07 · E.R. Squibb & Sons, L.L.C. · $260.57 ·
Open Payments source
-
2025-11-11 · E.R. Squibb & Sons, L.L.C. · $3,876.00 ·
Open Payments source
-
2025-11-20 · E.R. Squibb & Sons, L.L.C. · $35.93 ·
Open Payments source
-
2025-11-20 · E.R. Squibb & Sons, L.L.C. · $3,323.00 ·
Open Payments source
-
2025-11-26 · E.R. Squibb & Sons, L.L.C. · $340.01 ·
Open Payments source
-
2025-11-26 · E.R. Squibb & Sons, L.L.C. · $119.48 ·
Open Payments source
-
2025-12-15 · E.R. Squibb & Sons, L.L.C. · $41.48 ·
Open Payments source
|
NUPLAZID Normalized: nuplazid |
Drug |
ACADIA Pharmaceuticals Inc |
$35,924.76 |
60 |
2025 |
Source payment records
-
2025-01-14 · ACADIA Pharmaceuticals Inc · $10.27 ·
Open Payments source
-
2025-02-11 · ACADIA Pharmaceuticals Inc · $5.60 ·
Open Payments source
-
2025-02-24 · ACADIA Pharmaceuticals Inc · $22.54 ·
Open Payments source
-
2025-03-07 · ACADIA Pharmaceuticals Inc · $100.00 ·
Open Payments source
-
2025-03-20 · ACADIA Pharmaceuticals Inc · $3.13 ·
Open Payments source
-
2025-03-21 · ACADIA Pharmaceuticals Inc · $13.39 ·
Open Payments source
-
2025-03-27 · ACADIA Pharmaceuticals Inc · $1,250.00 ·
Open Payments source
-
2025-04-02 · ACADIA Pharmaceuticals Inc · $9.80 ·
Open Payments source
-
2025-04-10 · ACADIA Pharmaceuticals Inc · $2,000.00 ·
Open Payments source
-
2025-05-29 · ACADIA Pharmaceuticals Inc · $120.00 ·
Open Payments source
-
2025-05-30 · ACADIA Pharmaceuticals Inc · $1,250.00 ·
Open Payments source
-
2025-06-04 · ACADIA Pharmaceuticals Inc · $535.97 ·
Open Payments source
-
2025-06-04 · ACADIA Pharmaceuticals Inc · $101.58 ·
Open Payments source
-
2025-06-04 · ACADIA Pharmaceuticals Inc · $119.46 ·
Open Payments source
-
2025-06-06 · ACADIA Pharmaceuticals Inc · $311.37 ·
Open Payments source
-
2025-06-06 · ACADIA Pharmaceuticals Inc · $348.95 ·
Open Payments source
-
2025-06-20 · ACADIA Pharmaceuticals Inc · $262.76 ·
Open Payments source
-
2025-06-25 · ACADIA Pharmaceuticals Inc · $122.94 ·
Open Payments source
-
2025-06-25 · ACADIA Pharmaceuticals Inc · $118.55 ·
Open Payments source
-
2025-06-26 · ACADIA Pharmaceuticals Inc · $110.01 ·
Open Payments source
-
2025-06-26 · ACADIA Pharmaceuticals Inc · $87.04 ·
Open Payments source
-
2025-06-26 · ACADIA Pharmaceuticals Inc · $79.89 ·
Open Payments source
-
2025-06-26 · ACADIA Pharmaceuticals Inc · $23.78 ·
Open Payments source
-
2025-06-26 · ACADIA Pharmaceuticals Inc · $92.56 ·
Open Payments source
-
2025-06-26 · ACADIA Pharmaceuticals Inc · $111.21 ·
Open Payments source
-
2025-06-26 · ACADIA Pharmaceuticals Inc · $45.36 ·
Open Payments source
-
2025-06-26 · ACADIA Pharmaceuticals Inc · $2,000.00 ·
Open Payments source
-
2025-06-26 · ACADIA Pharmaceuticals Inc · $82.27 ·
Open Payments source
-
2025-07-02 · ACADIA Pharmaceuticals Inc · $8,500.00 ·
Open Payments source
-
2025-07-09 · ACADIA Pharmaceuticals Inc · $4,000.00 ·
Open Payments source
-
2025-07-23 · ACADIA Pharmaceuticals Inc · $57.69 ·
Open Payments source
-
2025-07-30 · ACADIA Pharmaceuticals Inc · $1,250.00 ·
Open Payments source
-
2025-08-08 · ACADIA Pharmaceuticals Inc · $50.00 ·
Open Payments source
-
2025-08-08 · ACADIA Pharmaceuticals Inc · $50.00 ·
Open Payments source
-
2025-08-08 · ACADIA Pharmaceuticals Inc · $60.00 ·
Open Payments source
-
2025-08-14 · ACADIA Pharmaceuticals Inc · $1,250.00 ·
Open Payments source
-
2025-08-15 · ACADIA Pharmaceuticals Inc · $58.54 ·
Open Payments source
-
2025-08-20 · ACADIA Pharmaceuticals Inc · $81.20 ·
Open Payments source
-
2025-08-20 · ACADIA Pharmaceuticals Inc · $93.91 ·
Open Payments source
-
2025-09-03 · ACADIA Pharmaceuticals Inc · $2,000.00 ·
Open Payments source
-
2025-10-25 · ACADIA Pharmaceuticals Inc · $12.12 ·
Open Payments source
-
2025-10-27 · ACADIA Pharmaceuticals Inc · $16.67 ·
Open Payments source
-
2025-10-27 · ACADIA Pharmaceuticals Inc · $51.13 ·
Open Payments source
-
2025-11-01 · ACADIA Pharmaceuticals Inc · $616.97 ·
Open Payments source
-
2025-11-14 · ACADIA Pharmaceuticals Inc · $99.41 ·
Open Payments source
-
2025-11-18 · ACADIA Pharmaceuticals Inc · $132.96 ·
Open Payments source
-
2025-11-20 · ACADIA Pharmaceuticals Inc · $55.28 ·
Open Payments source
-
2025-11-25 · ACADIA Pharmaceuticals Inc · $46.84 ·
Open Payments source
-
2025-11-25 · ACADIA Pharmaceuticals Inc · $123.81 ·
Open Payments source
-
2025-12-01 · ACADIA Pharmaceuticals Inc · $1,210.30 ·
Open Payments source
-
2025-12-04 · ACADIA Pharmaceuticals Inc · $2,000.00 ·
Open Payments source
-
2025-12-05 · ACADIA Pharmaceuticals Inc · $120.20 ·
Open Payments source
-
2025-12-10 · ACADIA Pharmaceuticals Inc · $3,500.00 ·
Open Payments source
-
2025-12-16 · ACADIA Pharmaceuticals Inc · $447.44 ·
Open Payments source
-
2025-12-16 · ACADIA Pharmaceuticals Inc · $426.31 ·
Open Payments source
-
2025-12-19 · ACADIA Pharmaceuticals Inc · $64.53 ·
Open Payments source
-
2025-12-19 · ACADIA Pharmaceuticals Inc · $8.74 ·
Open Payments source
-
2025-12-19 · ACADIA Pharmaceuticals Inc · $77.41 ·
Open Payments source
-
2025-12-19 · ACADIA Pharmaceuticals Inc · $61.61 ·
Open Payments source
-
2025-12-19 · ACADIA Pharmaceuticals Inc · $63.26 ·
Open Payments source
|
REXULTI Normalized: rexulti |
Drug |
Lundbeck LLC, Otsuka America Pharmaceutical, Inc. |
$30,190.73 |
40 |
2025 |
Source payment records
-
2025-03-04 · Otsuka America Pharmaceutical, Inc. · $210.87 ·
Open Payments source
-
2025-03-07 · Otsuka America Pharmaceutical, Inc. · $986.36 ·
Open Payments source
-
2025-03-08 · Otsuka America Pharmaceutical, Inc. · $2,548.00 ·
Open Payments source
-
2025-04-03 · Otsuka America Pharmaceutical, Inc. · $119.76 ·
Open Payments source
-
2025-04-11 · Otsuka America Pharmaceutical, Inc. · $2,548.00 ·
Open Payments source
-
2025-04-18 · Otsuka America Pharmaceutical, Inc. · $351.00 ·
Open Payments source
-
2025-05-08 · Otsuka America Pharmaceutical, Inc. · $125.00 ·
Open Payments source
-
2025-05-14 · Otsuka America Pharmaceutical, Inc. · $2,548.00 ·
Open Payments source
-
2025-05-22 · Otsuka America Pharmaceutical, Inc. · $25.61 ·
Open Payments source
-
2025-05-24 · Otsuka America Pharmaceutical, Inc. · $680.25 ·
Open Payments source
-
2025-05-30 · Otsuka America Pharmaceutical, Inc. · $12.60 ·
Open Payments source
-
2025-05-30 · Otsuka America Pharmaceutical, Inc. · $2,548.00 ·
Open Payments source
-
2025-06-27 · Otsuka America Pharmaceutical, Inc. · $877.50 ·
Open Payments source
-
2025-09-11 · Otsuka America Pharmaceutical, Inc. · $14.24 ·
Open Payments source
-
2025-09-24 · Otsuka America Pharmaceutical, Inc. · $121.83 ·
Open Payments source
-
2025-09-26 · Otsuka America Pharmaceutical, Inc. · $260.39 ·
Open Payments source
-
2025-09-27 · Otsuka America Pharmaceutical, Inc. · $4,312.00 ·
Open Payments source
-
2025-10-08 · Otsuka America Pharmaceutical, Inc. · $124.98 ·
Open Payments source
-
2025-10-08 · Otsuka America Pharmaceutical, Inc. · $260.37 ·
Open Payments source
-
2025-10-10 · Otsuka America Pharmaceutical, Inc. · $246.77 ·
Open Payments source
-
2025-10-15 · Otsuka America Pharmaceutical, Inc. · $4,312.00 ·
Open Payments source
-
2025-10-17 · Otsuka America Pharmaceutical, Inc. · $157.74 ·
Open Payments source
-
2025-10-17 · Otsuka America Pharmaceutical, Inc. · $89.81 ·
Open Payments source
-
2025-10-17 · Otsuka America Pharmaceutical, Inc. · $108.31 ·
Open Payments source
-
2025-10-17 · Otsuka America Pharmaceutical, Inc. · $6.17 ·
Open Payments source
-
2025-10-17 · Otsuka America Pharmaceutical, Inc. · $326.48 ·
Open Payments source
-
2025-10-21 · Otsuka America Pharmaceutical, Inc. · $341.95 ·
Open Payments source
-
2025-10-22 · Otsuka America Pharmaceutical, Inc. · $100.63 ·
Open Payments source
-
2025-10-22 · Otsuka America Pharmaceutical, Inc. · $47.74 ·
Open Payments source
-
2025-10-22 · Otsuka America Pharmaceutical, Inc. · $47.84 ·
Open Payments source
-
2025-10-22 · Otsuka America Pharmaceutical, Inc. · $99.03 ·
Open Payments source
-
2025-10-22 · Otsuka America Pharmaceutical, Inc. · $61.29 ·
Open Payments source
-
2025-11-11 · Otsuka America Pharmaceutical, Inc. · $121.65 ·
Open Payments source
-
2025-11-13 · Otsuka America Pharmaceutical, Inc. · $918.33 ·
Open Payments source
-
2025-11-19 · Otsuka America Pharmaceutical, Inc. · $764.40 ·
Open Payments source
-
2025-11-19 · Otsuka America Pharmaceutical, Inc. · $3,724.00 ·
Open Payments source
-
2025-11-20 · Otsuka America Pharmaceutical, Inc. · $8.36 ·
Open Payments source
-
2025-11-20 · Otsuka America Pharmaceutical, Inc. · $1.39 ·
Open Payments source
-
2025-12-11 · Otsuka America Pharmaceutical, Inc. · $11.96 ·
Open Payments source
-
2025-12-11 · Lundbeck LLC · $20.12 ·
Open Payments source
|
AUSTEDO XR Normalized: austedo xr |
Drug |
Teva Pharmaceuticals USA, Inc. |
$9,155.43 |
6 |
2025 |
Source payment records
|
SPRAVATO Normalized: spravato |
Drug |
Janssen Pharmaceuticals, Inc |
$9,095.95 |
11 |
2025 |
Source payment records
-
2025-04-24 · Janssen Pharmaceuticals, Inc · $479.14 ·
Open Payments source
-
2025-04-24 · Janssen Pharmaceuticals, Inc · $426.34 ·
Open Payments source
-
2025-04-24 · Janssen Pharmaceuticals, Inc · $289.80 ·
Open Payments source
-
2025-04-25 · Janssen Pharmaceuticals, Inc · $140.49 ·
Open Payments source
-
2025-04-25 · Janssen Pharmaceuticals, Inc · $14.59 ·
Open Payments source
-
2025-04-25 · Janssen Pharmaceuticals, Inc · $15.62 ·
Open Payments source
-
2025-04-26 · Janssen Pharmaceuticals, Inc · $8.82 ·
Open Payments source
-
2025-04-26 · Janssen Pharmaceuticals, Inc · $17.63 ·
Open Payments source
-
2025-04-26 · Janssen Pharmaceuticals, Inc · $29.41 ·
Open Payments source
-
2025-04-26 · Janssen Pharmaceuticals, Inc · $44.11 ·
Open Payments source
-
2025-05-09 · Janssen Pharmaceuticals, Inc · $7,630.00 ·
Open Payments source
|
ERZOFRI EXTENDED-RELEASE Normalized: erzofri extended release |
Drug |
Luye Pharma (USA) Ltd. |
$167.38 |
3 |
2025 |
Source payment records
|
UZEDY Normalized: uzedy |
Drug |
Teva Pharmaceuticals USA, Inc. |
$118.39 |
3 |
2025 |
Source payment records
|
INVEGA Normalized: invega |
Drug |
Janssen Pharmaceuticals, Inc |
$79.00 |
1 |
2025 |
Source payment records
|
ARISTADA Normalized: aristada |
Drug |
Alkermes, Inc. |
$66.99 |
3 |
2025 |
Source payment records
|
LYBALVI Normalized: lybalvi |
Drug |
Alkermes, Inc. |
$66.99 |
3 |
2025 |
Source payment records
|
ABILIFY ASIMTUFII Normalized: abilify asimtufii |
Drug |
Otsuka America Pharmaceutical, Inc. |
$33.84 |
1 |
2025 |
Source payment records
|
REJOYN Normalized: rejoyn |
Device |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
$26.89 |
1 |
2025 |
Source payment records
-
2025-07-14 · Otsuka Pharmaceutical Development & Commercialization, Inc. · $26.89 ·
Open Payments source
|
ZURZUVAE Normalized: zurzuvae |
Drug |
Biogen, Inc. |
$24.69 |
1 |
2025 |
Source payment records
|
APLENZIN Normalized: aplenzin |
Drug |
Bausch Health US, LLC |
$22.91 |
1 |
2025 |
Source payment records
|
WELLBUTRIN Normalized: wellbutrin |
Drug |
Bausch Health US, LLC |
$22.91 |
1 |
2025 |
Source payment records
|